The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term recurrence patterns in rectal cancer after neoadjuvant therapy: Insights from 25-years of real-world data.
 
Pieter Maerten
No Relationships to Disclose
 
Gertjan Rasschaert
Honoraria - Merck
Travel, Accommodations, Expenses - Ipsen; MSD; SERVIER
 
Gilles Defraene
No Relationships to Disclose
 
Evelien Dierick
No Relationships to Disclose
 
Cedric Schraepen
No Relationships to Disclose
 
Lynn Debrun
No Relationships to Disclose
 
Gabriele Bislenghi
No Relationships to Disclose
 
Andre D'hoore
No Relationships to Disclose
 
Freddy Penninckx
No Relationships to Disclose
 
Gert De Hertogh
No Relationships to Disclose
 
Philippe Leclercq
No Relationships to Disclose
 
Xavier Sagaert
No Relationships to Disclose
 
Raphaële Dresen
No Relationships to Disclose
 
Sabine Tejpar
Consulting or Advisory Role - Agenus; Boehringer Ingelheim; GlaxoSmithKline
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Research Funding - BMS GmbH & Co. KG; GlaxoSmithKline
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Jeroen Dekervel
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb Belgium; Eisai; Medtalks; MSD; Roche; Takeda
Speakers' Bureau - Amgen; AstraZeneca; BeiGene; Bristol-Myers Squibb; Ipsen; Merck; MSD; Roche
Travel, Accommodations, Expenses - Amgen; Ipsen; Roche; SERVIER
 
Filip Van Herpe
No Relationships to Disclose
 
Eric Van Cutsem
Consulting or Advisory Role - Abbvie; Agenus; ALX Oncology; Amgen; Arcus Biosciences; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Bexon Clinical Consulting; BioNTech SE; Boehringer Ingelheim; Bristol-Myers Squibb; Cantargia AB; Daiichi Sankyo; Debiopharm Group; Eisai; ElmediX; Fosum; Galapagos NV; GlaxoSmithKline; Ipsen; ITeos Therapeutics; Lilly; Merck KGaA; Merck Sharp & Dohme; Microbial Machines; Mirati Therapeutics; Nordic Group; Novartis; Novocure; Pfizer; Pierre Fabre; Sanofi; Seagen; SERVIER; Simcere; Taiho Pharmaceutical; Takeda; Trishula Therapeutics
 
Albert Wolthuis
No Relationships to Disclose
 
Karin Haustermans
Honoraria - Elsevier
Research Funding - IBA